Children with genetic podocytopathies who respond to calcineurin inhibitors kept their kidneys longer

Design

Multinational retrospective cohort

Population

136 children with genetic podocytopathies treated with calcineurin inhibitors at 34 centres

Primary outcome

Response sustainability and kidney survival

Effect

Sustained response 18%, none reached kidney failure; non-sustained response 92% lower risk vs non-responders

Genetic podocytopathies — usually presenting as steroid-resistant nephrotic syndrome — have often been treated as unresponsive to immunosuppression, and calcineurin inhibitors withheld once a pathogenic variant is found. This retrospective study pooled 136 children treated with a calcineurin inhibitor for at least three months at 34 paediatric nephrology centres worldwide.

Over a median 42 months, 71% never responded, 11% responded but lost the response, and 18% had a sustained response, defined by international paediatric criteria. No child with a sustained response developed kidney failure. Children whose response was not sustained still had a 92% lower risk of kidney failure than non-responders. At least partial response at six months was linked to lower proteinuria at later time points.

This is observational, and responders may have had milder variants or disease. But the absence of kidney failure among sustained responders is striking, and the cost of a time-limited trial is modest against the benefit for the minority who respond. Nephrotoxicity monitoring is needed throughout.

• Consider a time-limited calcineurin inhibitor trial in children with genetic podocytopathies, rather than ruling it out on genotype.
• Assess response at about six months by proteinuria; it was associated with later outcomes.
• Continue treatment in children who respond, with regular monitoring of drug levels and kidney function.
• Stop in non-responders to avoid nephrotoxicity without benefit.
• Expect only about one child in four or five to respond.

Why it matters

It challenges the assumption that a genetic diagnosis makes these drugs pointless.

Don't overread it

This was observational — it cannot show that calcineurin inhibitors themselves preserved kidney function.

The statistics, in plain English

A 92% lower risk of kidney failure means non-sustained responders reached kidney failure far less often than non-responders. Because response was not randomised, children who responded may have had milder disease to begin with.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.